---
title: "CytomX Q2 FY26 net loss widens to $20.67 million; revenue drops to $1.42 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295139511.md"
description: "CytomX Therapeutics reported a widened Q2 FY26 net loss of $20.67 million and revenue decline to $1.42 million, down 92.4% year-over-year due to eased collaboration activity. Operating expenses rose to $25.2 million, driven by R&D costs. Cash reserves decreased to $330.3 million, with a runway extending into late 2028. The company expects Varseta-M Phase 1 monotherapy updates in advanced CRC by end-2026 and its first registrational study in the first half of 2027."
datetime: "2026-08-06T20:24:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295139511.md)
  - [en](https://longbridge.com/en/news/295139511.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295139511.md)
generator: "portal-rs"
---

# CytomX Q2 FY26 net loss widens to $20.67 million; revenue drops to $1.42 million

-   CytomX posted Q2 revenue of USD 1.42 million, down 92.4% year over year as collaboration activity eased. \* Net loss attributable to common stockholders widened to USD 20.67 million; loss per share was USD 0.09. \* Operating loss widened to USD 23.78 million as operating expenses rose to USD 25.2 million, led by R&D costs of USD 17.6 million. \* Cash, cash equivalents and investments fell to USD 330.3 million at June 30 from USD 346.7 million at March 31; runway forecast into 2H 2028. \* Varseta-M Phase 1 monotherapy update in advanced CRC due by end-2026; first registrational CRC study targeted for 1H 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytomX Therapeutics Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CTMX.US](https://longbridge.com/en/quote/CTMX.US.md)

## Related News & Research

- [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md)
- [Northrop Grumman announces R$ 0.17 per unit dividend for Q3 2026](https://longbridge.com/en/news/296645808.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)
- [Kreditbanken posts 2026 half-year report release](https://longbridge.com/en/news/296349936.md)
- [Baker Hughes declares Q3 2026 dividend of R$ 0.81 per unit](https://longbridge.com/en/news/296392545.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**